Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
TRAMADOL IN THE TREATMENT OF POSTANESTHETIC SHIVERING
Autore:
DEWITTE J; DELOOF T; DEVEYLDER J; HOUSMANS PR;
Indirizzi:
OLV CLIN,DEPT ANESTHESIOL & CRIT CARE MED,MOORSELBAAN 164 B-9300 AALST BELGIUM OLV CLIN,DEPT ANESTHESIOL & CRIT CARE MED B-9300 AALST BELGIUM
Titolo Testata:
Acta anaesthesiologica Scandinavica
fascicolo: 4, volume: 41, anno: 1997,
pagine: 506 - 510
SICI:
0001-5172(1997)41:4<506:TITTOP>2.0.ZU;2-9
Fonte:
ISI
Lingua:
ENG
Soggetto:
MORPHINE; PAIN;
Keywords:
ANALGESICS, TRAMADOL; COMPLICATIONS, SHIVERING; PREMEDICATION; GLYCOPYRRONIUM, TRAMADOL;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
16
Recensione:
Indirizzi per estratti:
Citazione:
J. Dewitte et al., "TRAMADOL IN THE TREATMENT OF POSTANESTHETIC SHIVERING", Acta anaesthesiologica Scandinavica, 41(4), 1997, pp. 506-510

Abstract

Background: As an inhibitor of the reuptake of serotonin and norepinephrine in the spinal cord, the mechanism of action of tramadol resembles that of nefopam, which has been used in the treatment of postanesthetic shivering. Methods: In a randomized, placebo-controlled, double-blind study, we assessed the effects of tramadol (0.5 mg . kg(-1), 1 mg. kg(-1) and 2 mg . kg(-1) i.v.) or normal saline on shivering after a standardized general anesthesia in 40 adult patients, ASA physical status I or II (group 1), and in 64 adult patients regardless of the foregoing general anesthesia and ASA physical status (group 2). Results:Tramadol 1 mg . kg(-1) or more abolished shivering completely 5 min after treatment in all patients of groups 1 and 2. In group 1, the three dosages of tramadol were not statistically different in lowering theseverity and prevalence of postanesthetic shivering. Tramadol 0.5 mg . kg(-1) was significantly slower than tramadol 1 or 2 mg . kg(-1) in tempering the severity as well as lowering the prevalence of postanesthetic shivering in group 2. Conclusion: Tramadol's distinct features in the treatment of shivering reside in its high safety profile and weak sedative properties, particularly in patients with poor cardiorespiratory reserve, in outpatients and on recurrence of shivering. (C) ActaAnaesthesiologica Scandinavica 41 (1997).

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/10/20 alle ore 14:44:59